期刊文献+

重组非洲爪蟾和小鼠血管内皮细胞生长因子的原核表达、纯化及鉴定 被引量:4

Prokaryotic Expression,Purification and Identification of Recombinant Xenopus Laevis and Mouse Vascular Endothelial Growth Factors
在线阅读 下载PDF
导出
摘要 目的 构建非洲爪蟾和小鼠血管内皮细胞生长因子重组表达载体,进行蛋白质原核表达,并对表达产物进行分离、纯化和鉴定。方法 首先通过限制性核酸内切酶酶切及连接反应,构建非洲爪蟾和小鼠血管内皮细胞生长因子的原核表达载体p ET- x VEGF和p ET- m VEGF。筛选的重组质粒经酶切和DNA序列测定等证实正确性后,再转染感受态大肠杆菌BL 2 1(DE3) ,经IPTG诱导蛋白质表达。表达产物经Ni- NTA亲合层析及肠激酶特异性酶切进行分离纯化,最后用SDS- PAGE和蛋白免疫印迹法进行鉴定。结果 限制性核酸内切酶酶切和DNA序列测定等显示目的基因片段和阅读框架正确无误,表明非洲爪蟾和小鼠血管内皮细胞生长因子的原核表达载体p ET-x VEGF和p ET- m VEGF构建成功。重组蛋白质在大肠杆菌中获得稳定表达,分离纯化的表达产物x VEGF和m VEGF 的纯度达到95 %以上,其相对分子质量与预期值一致。抗小鼠VEGF抗体可特异性识别x VEGF和m VEGF。结论 重组非洲爪蟾和小鼠血管内皮细胞生长因子的原核表达、分离纯化及鉴定成功,为进一步研究异种VEGF蛋白质疫苗抗小鼠肿瘤模型奠定了基础。 Objective To perform prokaryotic expression, purification and identification of Xenopus laevis and mouse vascular endothelial growth factors(VEGF). Methods The prokaryotic expression vectors were constructed by restriction endonuclease digestion and ligation, then the recombinant vector pET-xVEGF and the control vector pET-mVEGF were identified by restriction enzymatic digestion and DNA sequencing. The confirmed vectors were transformed into Escherichia coli. BL21 (DE3) and recombinant protein expression was induced by Isopropy-β-D-thiogalactoside. The recombinant xVEGF and mVEGF were obtained and purified by Ni-NTA affinity chromatography under denature conditions and enterokinase specific digestion, respectively. Finally, the purified proteins' molecular weights and specificity were detected by SDS-PAGE and western blot analysis. Results Two new recombinant expression vectors, pET-xVEGF and pET-mVEGF, were constructed successfully. The xVEGF and mVEGF fusion proteins were expressed in E. coli. BL21 (DE3) stably, and the molecular weights of the purified xVEGF and mVEGF were identical to the expected values. The purity of final products reached a level higher than 95%. In addition, these two purified proteins could react with a specific antibody against mouse VEGF as expected. Conclusion Recombinant Xenopus laevis VEGF and its control mouse VEGF protein may provide tools for further study of anti-tumor active immunity with this xenogeneic protein vaccine in mouse tumor models.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2005年第3期301-304,共4页 Journal of Sichuan University(Medical Sciences)
基金 科技部基础研究重大项目前期研究专项 (国科基字 [2 0 0 1] 5 0号 ) 国家自然科学基金 (批准号 3 0 10 0 168)资助
关键词 血管内皮细胞生长因子 重组蛋白质 原核表达 Vascular endothelial growth factor(VEGF) Recombinant protein Prokaryotic expression
  • 相关文献

参考文献9

  • 1Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst,1990,82(1):4.
  • 2Takahashi Y, Kitadai Y, Bucana CD, et al. Expression of vascular endothelial growth factor and its receptor, KDR,correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res, 1995 , 55(18) : 3964.
  • 3Bellamy WT, Richter L, Grogan TM, et al. Expression of vascular endothelial growth factor and its receptors in haematopoietic malignances. Cancer Res, 1999 ; 59 (3) : 723.
  • 4Neufeld G, Cohen T, Gengrinovitch S, et al. Vascular endothelial growth factor(VEGF) and its receptors. FASEBJ,1999,13(1),9.
  • 5Wei YQ,Wang QR, Zhao X, et al. Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine. Nat Med,2000;6(10):1160.
  • 6Kornberg TB, Krasnow MA. The Drosophila genome sequence : implications for biology and medicine. Science,2000;287(5461) :2218.
  • 7Liu JY, Wei YQ, Yang L, et al. Immunotherapy of tumor with vaccine based on quail homologous vascular endothelial growth factor receptor-2. Blood, 2003 ; 102(5) z 1815.
  • 8Tan GH, Wei YQ, Tian L, et al. Active immunotherapy of tumors with a recombinant xenogeneic endoglin as a model antigen. Eur J Immunol,2004;34(7) :2012.
  • 9Wei YQ, Huang MJ, Yang L, et al. Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen. Proc Natl Acad Sci USA,2001.98(20) : 11545.

同被引文献36

  • 1Folkman J. What is the evidence that tumors are angiogenesis dependent [J]? J Nail Cancer Inst, 1990, 82(1): 4-6.
  • 2Fidler IJ, Ellis LM, The implications of angiogenesis for the biology and therapy of cancer metastasis [J], Cell, 1994,79(2) : 185 - 188.
  • 3Klement G, Baruehel S, Rak J, et al. Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity [ J]. J Clin Invest, 2000, 105(8): R15- R24.
  • 4Sweeney C j, Miller KD, Sissons SE, et al. The antiangiogenie property of docetaxel is synergistic with a recombinant humanized monoelonal antibody against vascular endothelial growth factor or 2-Methoxyestradiol but antagonized by endothelial growth factors [J]. Cancer Re.s, 2001, 61 (8):3 369- 3 372.
  • 5Gervasoni JE Jr,Hindenburg AA,Vezeridis NIP,et al.An effective in vitro antitumor response against human pancrreatic carcinoma with paclitaxel and daunorubicin by induction of both necrosis and apoptosis[J]. Anticancer Res, 2004,24(5A):2 617—2 626.
  • 6Kawakami K, Oka K, Kato M, et al. Whole-bladder irradiation and doxorubicin-containing chemotherapy as successful treatment for a primary mueosa-associated lymphoid tissue lymphoma of the bladder [J]. Int J Hematol, 2000, 72(3):346- 348.
  • 7Gupta A, Miki K, Xu M, et al. Combination efficacy of doxorubicin and adenoviral methioninase gene therapy with prodrug selenomethionine [J]. Anticancer Res, 2003,23 (2B): 1 181-1 188.
  • 8Nor JE, Christensen J, Mooney D J, et al. Vascular endothelial growth factor (VEGF) mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression [J]. Am J Pathol, 1999, 154 (2) : 375 -384.
  • 9Gupta A, Miki K, Xu M, et al. Combination efficacy of doxorubicin and adenoviral methioninase gene therapy with prodrug selenomethionine. Anticancer Res,2003;23(2B):1181.
  • 10Nor JE, Christensen J, Mooney DJ, et al. Vascular endothelial growth factor (VEGF) -mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol,1999;154(2):375.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部